Innovative therapeutics

Investors

NASDAQBMRN
FormDescriptionDateFormat
4Statement of changes in beneficial ownership of securitiesDec 29, 2014View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesDec 12, 2014View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesDec 8, 2014View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesDec 5, 2014View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesDec 3, 2014View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesDec 2, 2014View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesNov 28, 2014View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesNov 28, 2014View HTMLDownload DOCDownload PDFDownload XLS
4/AAmendment to a previously filed 4Nov 14, 2014View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesNov 14, 2014View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesNov 12, 2014View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesNov 12, 2014View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesNov 5, 2014View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesNov 5, 2014View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesNov 3, 2014View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesOct 31, 2014View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesOct 28, 2014View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesOct 23, 2014View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesSep 23, 2014View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesSep 3, 2014View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesAug 22, 2014View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesAug 7, 2014View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesAug 4, 2014View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesJul 3, 2014View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesJun 6, 2014View HTMLDownload DOCDownload PDFDownload XLS
1-25      26-50      51-75      76-89

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information